Insulin Storage: A Critical Reappraisal.

Lutz Heinemann, Katarina Braune, Alan Carter, Amin Zayani, Laura A Krämer
Author Information
  1. Lutz Heinemann: Science Consulting in Diabetes GmbH, Neuss, Germany. ORCID
  2. Katarina Braune: Department of Pediatric Endocrinology and Diabetes, Charité - Universitätsmedizin Berlin, Germany.
  3. Alan Carter: School of Pharmacy, University of Missouri-Kansas City, MO, USA.
  4. Amin Zayani: MedAngel BV, Nijmegen, The Netherlands.
  5. Laura A Krämer: MedAngel BV, Nijmegen, The Netherlands.

Abstract

Insulin, as a peptide hormone drug, is susceptible to changes in stability when exposed to environmental factors under storage. Proper storage according to the manufacturer's recommendations is important to maintain its potency and enable precise dosing for people with diabetes (PwD). While it is reasonable to assume that transport conditions and temperature are well controlled during the supply chain, little is known about insulin storage after dispensing and insulin potency at the moment of administration. Insulin is exposed to various environmental factors when carried by PwD and storage recommendations are often not met when it is stored in household refrigerators. It is difficult to assess changes in insulin potency in clinical practice, and there is a gap in the current scientific literature on insulin stability. Package leaflet recommendations only give limited information on the impact of improper storage conditions on insulin stability and guidelines by health organizations are inconsistent. Given the importance of precise dosing in diabetes care, there is a need for more transparency on insulin stability, awareness for proper storage among health care professionals and PwD as well as clear guidelines and practical storage recommendations from manufacturers and health organizations.

Keywords

References

  1. J Gastroenterol Hepatol. 2018 Feb;33(2):426-430 [PMID: 28800384]
  2. J Diabetes Sci Technol. 2012 Mar 01;6(2):265-76 [PMID: 22538135]
  3. Diabetes. 1968 Aug;17(8):499-502 [PMID: 5668013]
  4. J Am Pharm Assoc (2003). 2018 Jul - Aug;58(4S):S37-S40 [PMID: 29801995]
  5. Diabetes Technol Ther. 2019 Apr;21(4):209-214 [PMID: 30896261]
  6. Diabet Med. 2016 Nov;33(11):1544-1553 [PMID: 27472257]
  7. Endocr Pract. 2014 Feb;20(2):188-90 [PMID: 24246357]
  8. J Pharm Sci. 2014 Aug;103(8):2255-67 [PMID: 24909933]
  9. J Diabetes Sci Technol. 2016 Nov 1;10(6):1406-1410 [PMID: 27381029]
  10. Rev Calid Asist. 2010 Mar-Apr;25(2):64-9 [PMID: 19884029]
  11. Diabetes Care. 2004 May;27(5):1240-1; author reply 1241-2 [PMID: 15111563]
  12. J Diabetes Sci Technol. 2019 Jan;13(1):55-59 [PMID: 29952654]
  13. Am J Health Syst Pharm. 2008 May 15;65(10):953-63 [PMID: 18463345]
  14. J Biol Chem. 2018 Jan 5;293(1):47-68 [PMID: 29114035]
  15. Diabetes Care. 2004 May;27(5):1225-6 [PMID: 15111554]
  16. Rheumatology (Oxford). 2016 Apr;55(4):704-9 [PMID: 26672907]
  17. Diabetes Technol Ther. 2010 Sep;12(9):745-6 [PMID: 20687866]
  18. Diabete Metab. 1994 Jan-Feb;20(1):3-14 [PMID: 8056132]
  19. Diabetes Care. 2003 Sep;26(9):2665-6; discussion 266-9 [PMID: 12941735]
  20. J Pharm Biomed Anal. 1986;4(3):377-87 [PMID: 16867603]
  21. J Pharm Biomed Anal. 1989;7(2):185-8 [PMID: 2488619]
  22. Diabetes. 1972 Jul;21(7):805-13 [PMID: 5039832]
  23. BMJ. 2009 Jan 05;338:a2218 [PMID: 19124546]
  24. Pediatr Diabetes. 2018 Oct;19 Suppl 27:115-135 [PMID: 29999222]
  25. J Diabetes Sci Technol. 2014 Jul;8(4):850-4 [PMID: 24876429]
  26. Indian J Med Res. 2009 Aug;130(2):166-9 [PMID: 19797814]
  27. Diabetes Ther. 2019 Apr;10(2):341-366 [PMID: 30815830]
  28. J Diabetes Sci Technol. 2018 Jul;12(4):839-841 [PMID: 29268624]
  29. Lancet Diabetes Endocrinol. 2019 Aug;7(8):590-592 [PMID: 31178312]
  30. J Diabetes Sci Technol. 2019 Oct 22;:1932296819883291 [PMID: 31640422]
  31. ALTEX. 2017;34(4):565-566 [PMID: 29101770]
  32. Trop Med Int Health. 2000 Sep;5(9):666-7 [PMID: 11044282]
  33. J Diabetes Sci Technol. 2020 Jan;14(1):180-184 [PMID: 30782004]
  34. Diabetes Technol Ther. 2019 May;21(5):238-244 [PMID: 31009254]
  35. J Diabetes Sci Technol. 2010 Sep 01;4(5):1156-63 [PMID: 20920435]
  36. AAPS PharmSciTech. 2019 May 20;20(5):189 [PMID: 31111256]

MeSH Term

Drug Stability
Drug Storage
Humans
Insulin
Pharmaceutical Preparations
Refrigeration
Temperature

Chemicals

Insulin
Pharmaceutical Preparations

Word Cloud

Created with Highcharts 10.0.0insulinstoragestabilityrecommendationsInsulinpotencydiabetesPwDhealthchangesexposedenvironmentalfactorsprecisedosingconditionswellguidelinesorganizationscaretherapypeptidehormonedrugsusceptibleProperaccordingmanufacturer'simportantmaintainenablepeoplereasonableassumetransporttemperaturecontrolledsupplychainlittleknowndispensingmomentadministrationvariouscarriedoftenmetstoredhouseholdrefrigeratorsdifficultassessclinicalpracticegapcurrentscientificliteraturePackageleafletgivelimitedinformationimpactimproperinconsistentGivenimportanceneedtransparencyawarenessproperamongprofessionalsclearpracticalmanufacturersStorage:CriticalReappraisalHPLCconcentration

Similar Articles

Cited By